Rhodiola for Fatigue and Physical Performance

Does rhodiola rosea reduce fatigue and improve exercise performance in adults?

11 studies 551 participants 2009–2026

Evidence supports: Time-Trial Performance, Time to Exhaustion

No clear effect: Post-Exercise Muscle Recovery

Early data: General Fatigue, Endurance Exercise Performance, Post-Exercise Fatigue +3 more

Abstract

Rhodiola looks more credible as a modest exercise-performance aid than as a broad anti-fatigue supplement.²⁸⁹¹⁰¹¹ The strongest finding is that it helps people sustain hard effort a little longer before stopping, with a pooled effect in time-to-exhaustion tests that is small to moderate overall (d=0.75, 95% CI 0.26 to 1.23; I²=24.8%). That pattern also shows up in endurance-style tests such as Yo-Yo and 5 km performance, where the average effect is favorable but still based on small studies (d=0.50, 95% CI 0.12 to 0.89; I²=0%).⁸⁹¹⁰¹¹ By contrast, speed-type gains are modest. In one cycling time trial, acute rhodiola trimmed about 0.4 minutes, roughly 24 seconds, from a 6-mile effort, 25.4 versus 25.8 minutes.²

Rhodiola does not show a dependable ability to make people feel generally less tired across daily life or across very different fatigue settings.¹³⁴⁵ The pooled result for general fatigue was essentially neutral (d=0.05, 95% CI -0.73 to 0.83), and heterogeneity, meaning how much studies disagree with each other, was very high (I²=80.8%). One nursing-student trial actually found worse fatigue with rhodiola, with a 1.9-point increase on the VAS-Fatigue scale versus placebo after 42 days.⁴ A separate small exercise study found less post-exercise fatigue, but that signal comes from only 10 men and needs replication.⁵

Mental-performance findings fit the exercise story better than the fatigue story.¹⁶⁷¹¹ Reaction time improved on average across three trials (d=0.62, 95% CI 0.09 to 1.14; I²=20.1%), including roughly 27 milliseconds faster simple reaction time after 4 weeks in one study, 226.5 versus 253.5 ms.¹⁷¹¹ Taken together, the evidence reviewed here suggests rhodiola may work more through effort tolerance, alertness, and task focus than through a large reduction in tiredness itself.

In Plain Language

Rhodiola may be worth considering if the goal is to hold up a little better during hard exercise or mentally demanding training. It looks most useful for effort tolerance and focus, not for fixing everyday fatigue. If the main problem is feeling generally worn out or wanting faster recovery after workouts, this evidence does not give a strong reason to expect much.

Introduction

The practical question is not whether rhodiola has an interesting reputation, but whether it actually helps adults feel less fatigued or perform better when effort matters.¹²⁴⁷ That distinction matters because many supplements that seem energizing in theory end up showing only narrow benefits when tested carefully.

The current analysis points to a fairly specific answer: rhodiola appears more useful for sustaining performance during demanding exercise than for reliably reducing broad, day-to-day fatigue.²⁸⁹¹⁰¹¹ It also shows early signs of sharpening reaction time and alertness, which could help explain why exercise effects appear more coherent than fatigue-scale effects.¹⁵⁶⁷¹¹

That boundary is important. Most included studies were short, many were small, and the outcomes varied from cycling time trials to mood scales to reaction-time tasks.¹²⁴⁵⁷⁸ So the best-supported use case is not chronic fatigue relief. It is short-term support for staying switched on and holding effort a bit better under physical or mental strain.

Evidence 1 of 3

Better at sustaining hard effort than transforming performance

Rhodiola demonstrates its clearest benefit during exertion, especially by helping people last longer before exhaustion rather than turning them into dramatically faster performers.⁸⁹¹⁰¹¹ Across time-to-exhaustion outcomes, the pooled effect favored rhodiola with a small to moderate benefit (d=0.75, 95% CI 0.26 to 1.23; I²=24.8%). I-squared describes between-study inconsistency, and 24.8% means these studies were fairly aligned overall. In individual trials, the practical change could be meaningful: in one 4-week study combining eccentric training with salidroside, participants lasted about 6 minutes longer on an exhaustive cycling ramp test than sedentary placebo, 19.7 versus 13.7 minutes.⁹ Another short salidroside study found that participants maintained their number of hard treadmill intervals while placebo participants dropped off over time.⁸

Rhodiola also suggests a broader endurance benefit, but this evidence base is still small.²¹⁰¹¹ The pooled endurance-performance effect was favorable (d=0.50, 95% CI 0.12 to 0.89; I²=0%), which means the included studies pointed in the same direction. In practice, those gains looked like faster 5 km treadmill performance in professional basketball players after 28 days and better Yo-Yo IR2 distance in competitive football players after 4 weeks, with a fairly strong effect in the football study (g=0.82).¹⁰¹¹ Still, the total sample behind this outcome was only 108 people, so the average signal is promising rather than settled.

Rhodiola shows only modest evidence for making fixed-distance efforts faster.² In the clearest time-trial study, a single 3 mg/kg dose taken 1 hour before exercise improved a 6-mile cycling time by about 24 seconds, from 25.8 to 25.4 minutes.² That is real enough to matter in a lab test or a close competition, but it is not a dramatic performance jump. The pooled summary for time-trial performance was small overall (median d=0.40), which fits the broader pattern: rhodiola seems better at helping people hang on under strain than at producing a large speed surge.²

Rhodiola may also improve exercise economy a little, but that claim rests on one exploratory study.⁸ In healthy active young adults, 16 days of salidroside raised percent predicted oxygen uptake during high-intensity intermittent exercise from 79.6% to 82.7% (d=0.45). That suggests slightly better physiological support during repeated hard efforts, not a wholesale change in aerobic capacity.⁸ Because this outcome comes from a single small trial, it is best viewed as a mechanistic clue that fits the endurance findings, not as a standalone proven effect.

What this means

If rhodiola helps, the most believable benefit is getting through hard exercise with a little more staying power. Expect modest gains in sustaining effort, not a dramatic jump in speed or fitness.

Time to Exhaustion

Proven benefit Strong · 91

2 studies N=738 d_RE=0.75 (0.26 to 1.23) p=0.003 I²=25%

Proven modest benefit

I 2025 (n=20)

1.08

N 2024 (n=50)

0.62

Pooled

0.75

Favours control MCID Favours supplement

▸ GRADE Assessment

Domain	Rating	Reason
Risk of bias	No concern	3 papers, majority low risk
Inconsistency	No concern	no concerns (I²=25%, consistency=100%, PI crosses null)
Imprecision	No concern	N=738 meets OIS=400
Publication bias	No concern	k=3 usable (< 10), cannot assess per Cochrane 10.4
Indirectness	No concern	deferred to Phase 2 (#1546)
Overall certainty	High

Endurance Exercise Performance

Early data Limited · 40

3 studies N=108 d_RE=0.50 (0.12 to 0.89) p=0.011 I²=0%

Promising early signal

Y 2026 (n=24)

0.79

E 2013 (n=36)

0.14

J 2025 (n=48)

0.65

Pooled

0.50

Favours control MCID Favours supplement

▸ GRADE Assessment

Domain	Rating	Reason
Risk of bias	No concern	3 papers, majority low risk
Inconsistency	No concern	no concerns (I²=0%, consistency=100%, PI crosses null)
Imprecision	Very serious	N=108 far below OIS=400
Publication bias	No concern	k=3 usable (< 10), cannot assess per Cochrane 10.4
Indirectness	No concern	deferred to Phase 2 (#1546)
Overall certainty	Low

Time-Trial Performance

Proven benefit Strong · 92

1 study N=704

Proven modest benefit

Single study: E 2013, d=0.11 (n=18+18)

▸ GRADE Assessment

Domain	Rating	Reason
Risk of bias	No concern	2 papers, majority low risk
Inconsistency	No concern	no concerns (I²=25%, consistency=100%)
Imprecision	No concern	N=704 meets OIS=400
Publication bias	No concern	k=2 usable (< 10), cannot assess per Cochrane 10.4
Indirectness	No concern	deferred to Phase 2 (#1546)
Overall certainty	High

Exercise Economy

Early data Very early · 36

1 study N=50

Faint early signal

Single study: N 2024, d=0.44 (n=25+25)

▸ GRADE Assessment

Domain	Rating	Reason
Risk of bias	No concern	1 papers, majority low risk
Inconsistency	No concern	single study, inconsistency N/A
Imprecision	Very serious	single small study (N=50)
Publication bias	No concern	k=1 usable (< 10), cannot assess per Cochrane 10.4
Indirectness	No concern	deferred to Phase 2 (#1546)
Overall certainty	Low

Evidence 2 of 3

Fatigue relief is inconsistent, and recovery does not follow the performance signal

Rhodiola does not show a dependable effect on overall fatigue across the evidence reviewed here.¹³⁴⁵ The pooled result was essentially neutral (d=0.05, 95% CI -0.73 to 0.83; I²=80.8%). That high I-squared means the studies were telling conflicting stories rather than converging on one shared answer. One reason is that the measurement tools captured very different experiences: a stress-fatigue population, mountain-sickness weakness, shift-work fatigue, and exercise-related mood fatigue are not the same thing.¹³⁴⁵

Some fatigue results were positive, but they were not consistent enough to support a broad anti-fatigue claim.¹⁵ In a tiny acute exercise study of 10 active men, rhodiola improved BRUMS vigor from 5.7 to 7.6 and produced a large favorable post-exercise fatigue signal (d=1.54).⁵ In a stress-related fatigue trial, rhodiola also improved self-rated fatigue and some attention measures over 28 days.¹ But those encouraging results were offset by negative or null findings elsewhere.

The strongest contradiction came from a 42-day randomized trial in nursing students starting shift work, where rhodiola actually worsened fatigue versus placebo.⁴ The between-group difference was 1.9 points on the VAS-Fatigue scale, favoring placebo (95% CI 0.4 to 3.5; p=0.015). On a visual analog fatigue scale, higher scores reflect feeling more fatigued, so this was not a trivial statistical quirk but a directionally unfavorable result.⁴ A separate mountain-sickness trial also found essentially no effect on weakness or fatigue, 0.94 versus 0.99 on the Lake Louise weakness item.³

Rhodiola probably does not improve post-exercise muscle recovery, at least as measured by muscle-damage markers.⁸ In the only recovery study available, salidroside did not change CK-MM, a muscle-specific creatine kinase marker commonly used as a rough indicator of muscle damage, at pre-exercise, 24 hours, or 48 hours after exercise.⁸ That means rhodiola may help people tolerate effort without clearly speeding the repair process afterward.

What this means

Rhodiola should not be counted on as a reliable everyday fatigue reliever. It may change how effort feels in some settings, but it does not consistently make people less tired overall, and it does not appear to improve muscle recovery after exercise.

General Fatigue

Early data Limited · 43

3 studies N=264 d_RE=0.05 (-0.73 to 0.83) p=0.896 I²=81%

Barely detectable

T 2013 (n=204)

0.06

M 2014 (n=20)

1.05

S 2014 (n=40)

-0.76

Pooled

0.05

Favours control MCID Favours supplement

▸ GRADE Assessment

Domain	Rating	Reason
Risk of bias	No concern	4 papers, majority low risk
Inconsistency	Serious	I²=81% (> 75%)
Imprecision	Serious	N=264 below OIS=400
Publication bias	No concern	k=3 usable (< 10), cannot assess per Cochrane 10.4
Indirectness	No concern	deferred to Phase 2 (#1546)
Overall certainty	Low

Post-Exercise Fatigue

Early data Very early · 38

1 study N=20

Large effect, needs confirmation

Single study: M 2014, d=1.54 (n=10+10)

▸ GRADE Assessment

Domain	Rating	Reason
Risk of bias	No concern	2 papers, majority low risk
Inconsistency	No concern	no concerns (no data)
Imprecision	Very serious	N=20 far below OIS=400
Publication bias	No concern	k=1 usable (< 10), cannot assess per Cochrane 10.4
Indirectness	No concern	deferred to Phase 2 (#1546)
Overall certainty	Low

Post-Exercise Muscle Recovery

Likely no effect Strong · 60

0 studies N=0

Probably doesn't help

▸ GRADE Assessment

Domain	Rating	Reason
Risk of bias	No concern	1 papers, majority low risk
Inconsistency	No concern	single study, inconsistency N/A
Imprecision	Serious	sample size unknown
Publication bias	No concern	no d values
Indirectness	No concern	deferred to Phase 2 (#1546)
Overall certainty	Moderate

Evidence 3 of 3

Mental sharpness may contribute to the exercise story

Early findings hint that rhodiola may help people stay a bit sharper and respond a little faster, and this pattern fits the exercise results better than the broad fatigue data do.¹⁵⁶⁷¹¹ Across reaction-time outcomes, the pooled effect favored rhodiola (d=0.62, 95% CI 0.09 to 1.14; I²=20.1%). That is a small to moderate average improvement, and the low heterogeneity means the studies were more consistent than the fatigue literature.

Some of these reaction-time changes are large enough to imagine in real tasks, even if the evidence base is still small.⁷¹¹ In healthy young men, 4 weeks of 600 mg/day shortened simple reaction time by about 27 milliseconds, 226.5 versus 253.5 ms, and also improved total response time, 339.0 versus 352.5 ms.⁷ In competitive football players tested under fatigue, rhodiola improved decision reaction time after repeated-sprint work, with a strong effect size (g=0.83).¹¹ A stress-fatigue study showed only a trend toward faster Conners CPT-II hit reaction time, with p=0.06, so not every measure moved clearly.¹

Rhodiola may also modestly increase alertness or arousal during exercise, but that evidence comes from a single very small crossover trial.⁵ In active men given a single 3 mg/kg dose, felt arousal rose from 2.8 to 3.1 on the Felt Arousal Scale, and vigor increased on the BRUMS mood scale.⁵ Those shifts suggest being more switched on rather than less globally fatigued. That distinction helps explain why performance and reaction-time outcomes look more coherent than day-to-day fatigue scores.

The current analysis therefore suggests a plausible mechanism: rhodiola may help preserve attention, readiness, and willingness to sustain effort when demands rise.²⁵⁷⁸¹¹ Because several pooled positive outcomes still had prediction intervals crossing no effect, meaning future studies may not always reproduce the same benefit, this mechanism remains provisional rather than established.²⁷¹¹

What this means

Rhodiola may work more like a mild focus-and-effort aid than a true anti-fatigue supplement. The most plausible benefit is feeling a bit more mentally ready and losing less sharpness under strain.

Alertness and Mental Clarity

Early data Very early · 38

1 study N=20

Promising early signal

Single study: M 2014, d=0.59 (n=10+10)

▸ GRADE Assessment

Domain	Rating	Reason
Risk of bias	No concern	2 papers, majority low risk
Inconsistency	No concern	no concerns (no data)
Imprecision	Very serious	N=20 far below OIS=400
Publication bias	No concern	k=1 usable (< 10), cannot assess per Cochrane 10.4
Indirectness	No concern	deferred to Phase 2 (#1546)
Overall certainty	Low

Reaction Time

Early data Limited · 41

3 studies N=105 d_RE=0.62 (0.09 to 1.14) p=0.021 I²=20%

Faint early signal

Y 2026 (n=24)

0.80

E 2009 (n=55)

0.23

E 2018 (n=26)

1.07

Pooled

0.62

Favours control MCID Favours supplement

▸ GRADE Assessment

Domain	Rating	Reason
Risk of bias	No concern	4 papers, majority low risk
Inconsistency	No concern	no concerns (I²=20%, consistency=100%, PI crosses null)
Imprecision	Very serious	N=105 far below OIS=400
Publication bias	No concern	k=3 usable (< 10), cannot assess per Cochrane 10.4
Indirectness	No concern	deferred to Phase 2 (#1546)
Overall certainty	Low

Across the Evidence

The studies fit together best if rhodiola is viewed as a performance-context supplement rather than a general energy supplement.²⁵⁸⁹¹⁰¹¹ The clearest benefits appear when people are already under load, during time-to-exhaustion tests, repeated hard intervals, sport-specific endurance work, or fatigued decision-making. That pattern makes biological sense for an herb often framed as an adaptogen: the effect may emerge when stress regulation, perceived effort, or attentional control are being challenged, not when someone simply rates how tired they feel in daily life.¹⁵⁷

The mismatch between fatigue scales is one of the most important reasons not to overgeneralize the positive findings.¹³⁴⁵ BRUMS-based exercise mood outcomes looked favorable in one tiny study, but the VAS-Fatigue in shift-working nursing students moved in the wrong direction, and the Lake Louise weakness item in a mountain setting showed no meaningful change.³⁴⁵ These are not interchangeable measures. Some capture acute exertional states, some capture generalized tiredness, and some are bundled into altitude-sickness symptom checklists. When an effect depends heavily on which scale is used, confidence in a broad real-world fatigue benefit should drop.

The cognitive findings give the exercise story a more coherent backbone.¹⁶⁷¹¹ Faster reaction time, slightly higher arousal, and improved decision speed under fatigue all point in the same direction: rhodiola may help preserve task engagement when effort accumulates. That would explain why it can improve sustaining effort without consistently changing global fatigue scores or muscle-damage markers.⁵⁸¹¹

Several favorable pooled outcomes still carry an important warning label: their prediction intervals crossed no effect.⁸⁹¹⁰¹¹ A prediction interval estimates where the true result of a future comparable study may land, not just the average across existing studies. When it crosses null, benefit is likely real on average, but not equally reliable across populations, doses, or test formats. That is exactly what this evidence base looks like: promising, but context-sensitive.

Methodology probably matters as much as biology here.²⁴⁸⁹ Many trials were short, small, and used different preparations, whole-root extracts, standardized rosavin products, or salidroside-focused formulations, at doses ranging from 3 mg/kg acutely to 2.4 g/day chronically. Some studies also paired supplementation with training, which makes it harder to isolate what rhodiola alone is doing.⁹ Together, those design differences make the overall pattern interpretable, but they limit any precise statement about the best dose or the single most effective form.

Discussion

The bottom line is that rhodiola suggests a modest, believable role in helping adults sustain hard effort, but it does not earn the same confidence as a reliable anti-fatigue supplement.²⁸⁹¹⁰¹¹ The strongest support sits with time to exhaustion and exercise-related performance maintenance, where multiple randomized trials point in the same direction. The likely lived experience is not feeling transformed, but hanging on a little longer, fading a little less, and perhaps staying a bit sharper while doing it.

Confidence drops when the question shifts from performance under strain to general fatigue relief.¹³⁴⁵ Here the studies disagree too much, the pooled effect is essentially nil, and one good-quality trial showed worse fatigue with rhodiola during shift work.⁴ That does not prove rhodiola increases fatigue in general. It does mean the current analysis does not support selling it as a dependable remedy for feeling tired.

Recovery is the other major boundary.⁸ The evidence reviewed here probably does not support a benefit for post-exercise muscle recovery, at least if recovery is defined by muscle-damage biomarkers such as CK-MM. So the emerging picture is narrower and more useful: rhodiola may help during the work, not necessarily after it.

What would change this conclusion is not one more positive pilot study, but larger, better standardized trials that use the same fatigue scales, similar exercise protocols, and clearly characterized extracts.²⁴⁸¹¹ Replication is especially needed for post-exercise fatigue, alertness, and exercise economy, where the most favorable signals currently come from single studies. Until then, rhodiola is best viewed as a targeted option for acute performance and focus support, not a broadly validated solution for chronic tiredness or recovery.

Methodology

We searched PubMed for studies on rhodiola and fatigue or physical performance, then reviewed the 11 included human randomized or crossover trials identified in the PRISMA flow.¹²³⁴⁵⁶⁷⁸⁹¹⁰¹¹ We read each study, recorded what it measured, how large it was, and what it found, then assessed evidence quality with GRADE and judged clinical importance against published meaningful-change thresholds.

GRADE is useful, but it was designed for pharmaceutical interventions and often rates nutrition and supplement evidence conservatively. It automatically downgrades observational evidence and rarely upgrades unless effects are very large, typically above a relative risk of 2.0. Our parallel trust score gives a more continuous picture by combining study quality, consistency, precision, and whether the size of change is likely to be noticeable. That is why a nutrition outcome can read as practically convincing even when GRADE language still sounds cautious.

All studies cited here are publicly indexed on PubMed. Known limitations are straightforward: most trials were short, many were small, formulations differed, and several outcomes relied on only 1 to 3 studies. That means this review is strongest for short-term, performance-related questions and weaker for chronic fatigue or recovery claims.

Study Selection

52 Papers in rhodiola corpus

1 wrong study type

12 With matching outcomes

11 After study type & comparator filters

11 Included in review

Characteristics of Included Studies

Study	Design	N	Population	Dose	Duration	RoB
E 2009 FT	rct	60	clinical	576 mg daily for 28 days	28 days	Low
E 2013 FT	rct	18	healthy	3 mg/kg once, 1 hour before exercise	Acute single-dose crossover design; testing sessions 2–7 days apart	High
T 2013 FT	rct	125	healthy	800 mg daily for 9 days	Two treatment periods of 9 days each (7 days pre-ascent + 2 days during mountaineering) with a 3-month washout between periods.	Some
S 2014 FT	rct	48	healthy	364–546 mg daily for 42 days	42 days	Low
M 2014 FT	crossover trial	10	healthy	3 mg/kg, single dose 60 min before exercise	Acute single-dose protocol; two experimental trials separated by 48–72 hours; each trial comprised a single 30-minute submaximal cycling bout (70% VO2max).	Some
H 2016 FT	crossover trial	112	healthy	60 mg daily for 10 days	10 days	Low
E 2018 FT	rct	26	healthy	600 mg daily (3 × 200 mg) for 4 weeks	4 weeks	Some
N 2024 FT	rct	50	healthy	60 mg/day (30 mg twice daily) for 16 days	16 days	Some
I 2025 FT	rct	30	healthy	150 mg daily for 4 weeks	4 weeks	Some
J 2025 FT	rct	48	healthy	2.4 g daily for 28 days	28 days	Some
Y 2026 FT	rct	24	healthy	2.4 g daily for 4 weeks	4 weeks	Low

Sources